研究業績

研究業績2022年度　英文

詳細

研究業績2022年度　英文（原著、総説、症例報告）

 

  1. Abe S, Tanaka T, Fukuma K, Matsubara S, Motoyama R, Mizobuchi M, Yoshimura H, Matsuki T, Manabe Y, Suzuki J, Ishiyama H, Tojima M, Kobayashi K, Shimotake A, Nishimura K, Koga M, Toyoda K, Murayama S, Matsumoto R, Takahashi R, Ikeda A, Ihara M; PROPOSE Study Investigators. Interictal epileptiform discharges as a predictive biomarker for recurrence of poststroke epilepsy. Brain Commun. 2022;4:fcac312

 

  1. Ando Y, Adams D, Benson MD, Berk JL, Planté-Bordeneuve V, Coelho T, Conceição I, Ericzon BG, Obici L, Rapezzi C, Sekijima Y, Ueda M, Palladini G, Merlini G. Guidelines and new directions in the therapy and monitoring of ATTRv amyloidosis Amyloid. 2022;29:143-155

 

  1. Coelho T, Waddington Cruz M, Chao CC, Parman Y, Wixner J, Weiler M, Barroso FA, Dasgupta NR, Jung SW, Schneider E, Viney NJ, Dyck PJB, Ando Y, Gillmore JD, Khella S, Gertz MA, Obici L, Berk JL. Characteristics of patients with hereditary transthyretin amyloidosis-polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an open-label phase 3 study of Eplontersen. Neurol Ther, 2023;12:267-287

 

  1. Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM. Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging. J Card Fail. 2022;28:e1-e4

 

  1. Goto M, Tasaki M, Ueda M. Early onset Congo red-positive fibrillary glomerulonephritis associated with glomerular DNAJB9 deposits mimicking renal amyloidosis. Pathol Int. 2023;73:106-108

 

  1. Hashimoto Y, Komori M, Tanji Y, Ozeki A, Hirata K. Lasmiditan for single migraine attack in Japanese patients with cardiovascular risk factors: subgroup analysis of a phase 2 randomized placebo-controlled trial. Expert Opin Drug Saf. 2022;21:1495-1503

 

  1. Hayashi H, Oda S, Kidoh M, Nakaura T, Morita K, Nagayama Y, Yoneda T, Takashio S, Misumi Y, Ueda M, Tsujita K, Hirai T. Can myocardial susceptibility quantification be an imaging biomarker for cardiac amyloidosis? Jpn J Radiol. 2022;40:500-507

 

  1. Inatomi Y, Suzuki Y, Yonehara T, Nakajima M. Tremor-like grasp phenomenon: case series study. Neurol Sci. 2022;43:5927-5932

 

  1. Inoue M, Higashi T, Hayashi Y, Onodera R, Fujisawa K, Taharabaru T, Yokoyama R, Ouchi K, Misumi Y, Ueda M, Inoue Y, Mizuguchi M, Saito T, Saido TC, Ando Y, Arima H, Motoyama K, Jono H. Multifunctional therapeutic cyclodextrin-appended dendrimer complex for treatment of systemic and localized amyloidosis. ACS Appl Mater Interfaces. 2022;14:40599-40611

 

  1. Inoue M, Muta K, Mohammed AFA, Onodera R, Higashi T, Ouchi K, Ueda M, Ando Y, Arima H, Jono H, Motoyama K. Feasibility study of dendrimer-based TTR-CRISPR pDNA polyplex for ocular amyloidosis in vitro. Biol Pharm Bull. 2022;45:1660-1668

 

  1. Inoue Y, Nakajima M, Inatomi Y, Masuda T, Misumi Y, Nomura T, Uetani H, Hirai T, Ueda M. Reversible Periventricular Hyperintensity Lesions in Cerebral Amyloid Angiopathy: A Case Mimicking Cerebral Amyloid Angiopathy-related Inflammation. Intern Med. 2022;61:3581-3584

 

  1. Inoue Y, Tasaki M, Masuda T, Misumi Y, Nomura T, Ando Y, Ueda M. α-Enolase reduces cerebrovascular Aβ deposits by protecting Aβ amyloid formation. Cell Mol Life Sci. 2022;79:462

 

  1. Iwahashi N, Ikezaki M, Komohara Y, Fujiwara Y, Noguchi T, Nishioka K, Sakai K, Nishio K, Ueda M, Ihara Y, Uchimura K, Ino K, Nishitsuji K. Cytoplasmic p53 aggregates accumulated in p53-mutated cancer correlate with poor prognosis. PNAS Nexus. 2022;1:pgac128

 

  1. Kawano Y, Hata H, Takashio S, Tsujita K, Ueda M, Matsuoka M. Daratumumab, lenalidomide and dexamethasone in newly diagnosed systemic light chain amyloidosis patients associated with multiple myeloma. Br J Haematol. 2022;198:e38-e41

 

  1. Kidoh M, Oda S, Takashio S, Hirakawa K, Kawano Y, Shiraishi S, Hayashi H, Nakaura T, Nagayama Y, Funama Y, Ueda M, Tsujita K, Hirai T. Diagnostic performance of CT-derived extracellular volume fraction versus myocardium-to-lumen signal ratio for detecting cardiac amyloidosis. Radiology. 2023;306:e220542

 

  1. Kinoshita Y, Ikeda T, Miyamura T, Ueda Y, Yoshida Y, Ueda M, Haraoka S, Kushima H, Ishii H. Nodular Pulmonary Amyloidosis Associated with Sjögren’s Syndrome. Intern Med. 2022;61:877-881

 

  1. Kuyama N, Takashio S, Nagakura T, Imamura M, Takamatsu K, Takae M, Hirakawa K, Yamanaga K, Hanatani S, Yamamoto E, Matsushita K, Ueda M, Tsujita K. Anti-Kv1.4 antibody positive myocarditis and myositis despite absence of thymoma and anti-acetylcoline receptor antibody. JACC Case Rep. 2023;9:101734

 

  1. Maeda-Ogata S, Tahara N, Bekki M, Tahara A, Sugiyama Y, Honda A, Igata S, Abe T, Ueda M, Ando Y, Hirooka Y, Fukumoto Y. Carpal tunnel syndrome as an early red-flag sign of ATTRwt amyloidosis. J Nucl Cardiol. 2022;29;3562-3563

 

  1. Maeda-Ogata S, Tahara N, Tahara A, Bekki M, Honda A, Sugiyama Y, Igata S, Abe T, Sekijima Y, Ueda M, Ando Y, Fukumoto Y. Treatment response to Tafamidis quantitatively assessed by serial bone scintigraphy in transthyretin amyloid cardiomyopathy. J Nucl Cardiol. 2023;30:403-404

 

  1. Matsushita H, Misumi Y, Masuda T, Okada M, Inoue F, Ueda M, Ando Y. Urinary transthyretin as a biomarker in ATTRv Val50Met amyloidosis. Pathophysiology. 2022;29:333-343

 

  1. Matsushita H, Sameshima G, Fukunari A, Okada M, Inoue F, Ueda M, Ando Y. Suppression of amyloid fibril formation by UV irradiation. J Rad Res Appl Sci. 2022;15:100484

 

  1. Misumi I, Wada K, Sato K, Tabira A, Usuku H, Tsujita K. Advent of paradoxical flow after antihypertensive treatment in mid-ventricular obstructive hypertrophic cardiomyopathy – A case report. J Cardiol Cases. 2023;27:192-195

 

  1. Misumi Y, Ando Y, Ueda M. Early transverse tubule involvement in cardiomyocytes in hereditary transthyretin amyloidosis: a possible cause of cardiac events. Cardiovasc Pathol. 2022;61:107458

 

  1. Misumi Y, Tabata Y, Tasaki M, Obayashi K, Yamakawa S, Nomura T, Ueda M. Binding of serum-derived amyloid-associated proteins to amyloid fibrils. Amyloid. 2023;30:67-73

 

  1. Mizutani H, Sato Y, Yamazaki M, Yoshizawa T, Ando Y, Ueda M, Yamagata K. SIRT7 Deficiency Protects against Aβ42-Induced Apoptosis through the Regulation of NOX4-Derived Reactive Oxygen Species Production in SH-SY5Y Cells. Int J Mol Sci. 2022;23:9027

 

  1. Morioka M, Takashio S, Nakashima N, Nishi M, Fujiyama A, Hirakawa K, Hanatani S, Usuku H, Yamamoto E, Kidoh M, Oda S, Matsushita K, Ueda M, Tsujita K. Correlation between cardiac images, biomarkers, and amyloid load in wild-type transthyretin amyloid cardiomyopathy. J Am Heart Assoc. 2022;11:e024717

 

  1. Moriyama H, Kitakata H, Endo J, Ikura H, Sano M, Tasaki M, Sakai S, Ueda M, Fukuda K. Step-by-step typing for the accurate diagnosis of concurrent light chain and transthyretin cardiac amyloidosis. ESC Heart Fail. 2022;9:1474-1477

 

  1. Murakami Y, Wei F, Kawamura Y, Horiguchi H, Kadomatsu T, Miyata K, Miura K, Oike Y, Ando Y, Ueda M, Tomizawa K, Chujo T. NSUN3-mediated mitochondrial tRNA 5-formylcytidine modification is essential for embryonic development and respiratory complexes in mice. Commun Biol. 2023;6:307

 

  1. Naganuma M, Inatomi Y, Yonehara T, Nakajima M, Ueda M. Underdosed Direct Oral Anticoagulants in Atrial Fibrillation Patients Reduce Stroke Severity and Improve Outcome. Cerebrovasc Dis. 2022;51:473-480

 

  1. Nakahara K, Nakajima M. Asymmetric skin temperature in Wallenberg syndrome. Neurol India. 2022;70:2326-2327

 

  1. Nakahara K, Nakane S, Ishii K, Ikeda T, Ando Y. Gut microbiota of Parkinson’s disease in an appendectomy cohort: a preliminary study. Sci Rep. 2023;13:2210

 

  1. Nakahara K, Nakane S, Terasaki T, Ando Y. Effect of phosphatidic acid on antiganglioside antibody reactivity in the isolated facial diplegia variant of Guillain-Barré syndrome: a case report. Acta Neurol Belg. 2023;123:231-232

 

  1. Nakahara K, Takamatsu K, Kudo N, Ito T, Ueda M. Histopathological Features of Gerhardt Syndrome in a Patient With Multiple System Atrophy: An Autopsy Case Report. Cureus 2022;14:e30415

 

  1. Nakajima M, Watari M, Ando Y, Ueda M. Asymptomatic deep venous thrombosis identified on routine screening in patients with hospitalized neurological diseases. J Clin Neurosci. 2022;102:13-20

 

  1. Nakashima N, Takashio S, Morioka M, Nishi M, Yamada T, Hirakawa K, Ishii M, Tabata N, Yamanaga K, Fujisue K, Sueta D, Kanazawa H, Hoshiyama T, Hanatani S, Araki S, Usuku H, Yamamoto E, Ueda M, Matsushita K, Tsujita K. A simple staging system using biomarkers for wild-type transthyretin amyloid cardiomyopathy in Japan. ESC Heart Fail. 2022;9:1731-1739

 

  1. Nishi M, Takashio S, Morioka M, Fujiyama A, Nakashima N, Hirakawa K, Hanatani S, Usuku H, Yamamoto E, Kidoh M, Oda S, Gushima R, Matsushita K, Fukushima S, Ueda M, Tsujita K. Extracardiac biopsy sensitivity in transthyretin amyloidosis cardiomyopathy patients with positive 99 mTc-labeled pyrophosphate scintigraphy findings. Circ J, 86:1113-1120, 2022

 

  1. Oike F, Usuku H, Yamamoto E, Marume K, Takashio S, Ishii M, Tabata N, Fujisue K, Yamanaga K, Sueta D, Hanatani S, Arima Y, Araki S, Oda S, Kawano H, Soejima H, Matsushita K, Ueda M, Fukui T, Tsujita K. Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis. ESC Heart Fail. 2022;9:1976-1986

 

  1. Onishi H, Yamamura O, Tsubouchi H, Hirobe T, Enomoto S, Yamamoto T, Daitoku S, Mizukami Y, Kishimoto T, Kai Y,Hashimoto Y, Hmano T, Kaku B, Terasawa H. Long-term prevalence of disaster-related deep vein thrombosis in Minami Aso Village after the 2016 Kumamoto Earthquakes: a prospective cross-sectional analysis. Disaster Med Public Health Prep. 2022;16:2036-2043

 

  1. Quan D, Obici L, Berk JL, Ando Y, Aldinc E, White MT, Adams D. Impact of baseline polyneuropathy severity on patisiran treatment outcomes in the APOLLO trial. Amyloid. 2023;30:49-58

 

  1. Sato K, Oda S, Kidoh M, Ishiuchi S, Kamimoto M, Kanaya H, Nomura T, Kuyama N, Ueda M, Tsujita K, Hirai T. Myocarditis in myasthenia gravis: Multiparametric evaluation using cardiac magnetic resonance imaging. Circ J. 2022;86:1788

 

  1. Shimamoto T, Uchino K, Mori A, Nojima K, Iijima J, Misumi Y, Ueda M, Uchino M. Effects of intensive exercise on cognitive dysfunction in patients with pure cerebellar degeneration: A single-arm pilot study. Ann Rehabil Med. 2022;46:263-273

 

  1. Shinriki S, Hirayama M, Nagamachi A, Yokoyama A, Kawamura T, Kanai A, Kawai H, Iwakiri J, Riu L, Maeshiro M, Tungalag S, Tasaki M, Ueda M, Tomizawa K, Kataoka N, Ideue T, Suzuki Y, Asai K, Tani T, Inaba T, Matsui H. DDX41 coordinates RNA splicing and transcriptional elongation to prevent DNA replication stress in hematopoietic cells. Leukemia, 36: 2605-2620, 2022

 

  1. Tahara N, Honda A, Ueda M, Fukumoto Y. Popeye’s sign and transthyretin amyloidosis. Eur Heart J. 2022;43:3000

 

  1. Takahashi K, Hiratsuka Y, Sasaki D, Sakaue T, Enomoto D, Morioka H, Uemura S, Okura T, Ikeda S, Kono T, Iwamura T, Yamamura N, Kitazawa S, Ueda M. 99mTc-pyrophosphate scintigraphy can image tracer uptake in skeletal trunk muscles of transthyretin cardiac amyloidosis. Clin Nucl Med. 2023;48:18-24

 

  1. Takahashi K, Sasaki D, Yamashita M, Sakaue T, Enomoto D, Morioka H, Uemura S, Okura T, Ikeda S, Kono T, Hiratsuka Y, Saijo A, Yamamura N, Kitazawa S, Yamashita T, Ueda M. Amyloid deposit corresponds to technetium-99mpyrophosphate accumulation in abdominal fat of patients with transthyretin cardiac amyloidosis. J Nucl Cardiol. 2022;29:3126-3136

 

  1. Takahashi Y, Date H, Oi H, Adachi T, Imanishi N, Kimura E, Takizawa H, Kosugi S, Matsumoto N, Kosaki K, Matsubara Y; IRUD Consortium, Mizusawa H. Six years’ accomplishment of the Initiative on Rare and Undiagnosed Diseases: nationwide project in Japan to discover causes, mechanisms, and cures. J Hum Genet. 2022;67:505-513

 

  1. Takashio S, Tokitsu T, Matsukawa M, Sakaino N, Fujimoto K, Sakamoto T, Noda K, Tsunoda R, Misumi I, Hirai N, Doi H, Koide S, Mizuno Y, Hirose T, Kurokawa H, Kajiwara I, Ohba K, Miyamoto S, Araki S, Yamamoto E, Matsushita K, Ueda M, Tsujita K. Kumamoto Cardiac Amyloid Survey Investigators. Incidence, clinical characteristics, and diagnostic approach in transthyretin amyloid cardiomyopathy: The Kumamoto Cardiac Amyloidosis Survey. J Cardiol. 2022;80:49-55

 

  1. Tanaka H, Matsushita H, Tokuhiro K, Fukunari A, Ando Y. Ingestion of soybean sprouts containing a HASPIN inhibitor improves condition in a mouse model of alzheimer’s disease Biology (Basel). 2023;12:320

 

  1. Tanaka H, Nishida-Fukuda H, Wada M, Tokuhiro K, Matsushita H, Ando Y. Inhibitory effect of the HASPIN inhibitor CHR-6494 on BxPC-3-Luc, A luciferase-expressing pancreatic cancer cell line. Cell J. 2022;24:212-214

 

  1. Tanaka T, Fukuma K, Abe S, Matsubara S, Ikeda S, Kamogawa N, Ishiyama H, Hosoki S, Kobayashi K, Shimotake A, Nakaoku Y, Ogata S, Nishimura K, Koga M, Toyoda K, Matsumoto R, Takahashi R, Ikeda A, Ihara M. Association of cortical superficial siderosis with post-stroke epilepsy. Ann Neurol. 2023;93:357-370

 

  1. Taniguchi A, Shindo A, Tabei KI, Onodera O, Ando Y, Urabe T, Kimura K, Kitagawa K, Miyamoto Y, Takegami M, Ihara M, Mizuta I, Mizuno T, Tomimoto H. Imaging characteristics for predicting cognitive impairment in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Front Aging Neurosci. 2022;14:876437

 

  1. Tasaki M, Misumi Y, Nomura T, Kamba T, Ueda M. Detection of semenogelin 1 amyloidosis through immunohistochemical staining with novel antiserum developed based on mass spectrometric peptide mapping analysis. Amyloid. 2022;29:278-280

 

  1. Tasaki M, Nomura T, Uchiyama K, Misumi Y, Nakahara K, Oyama Y, Uesugi N, Ueda M. Fibrinogen Aalpha-chain amyloidosis associated with a rare frameshift pathogenic variant p. Arg547GlyfsTer21. Amyloid. 2022;29:276-277

 

  1. Ueda A, Nakajima M, Misumi Y, Nakahara K, Shinriki S, Tasaki M, Matsui H, Ueda M. Detection of Vascular Notch3 Deposits in Unfixed Frozen Skin Biopsy Sample in CADASIL. Front Neurol. 2022;13:881528

 

  1. Ueda M. Transthyretin: its function and amyloid formation. Neurochem Int. 2022;155:105313

 

  1. Usuku H, Takashio S, Yamamoto E, Yamada T, Egashira K, Morioka M, Nishi M, Komorita T, Oike F, Tabata N, Ishii M, Yamanaga K, Fujisue K, Sueta D, Arima Y, Araki S, Oda S, Misumi Y, Kawano H, Matsushita K, Ueda M, Matsui H, Tsujita K. Prognostic value of right ventricular global longitudinal strain in transthyretin amyloid cardiomyopathy. J Cardiol 80: 56-63, 2022

 

  1. Usuku H, Yamamo E, Sueta D, Noguchi M, Fujisaki T, Egashira K, Morioka M, Komorita T, Oike F, Fujisue K, Hanatani S, Arima Y, Takashio S, Oda S, Kawano H, Matsushita K, Ueda M, Matsui H, Tsujita K. Time-dependent change of relative apical longitudinal strain index in patients with wild-type transthyretin amyloid cardiomyopathy. Int J Cardiol Heart Vasc. 2022;43:101146

 

  1. Yagita K, Noguchi H, Koyama S, Hamasaki H, Komori T, Aishima S, Kosaka T, Ueda M, Komohara Y, Watanabe A, Sasagasako N, Ninomiya T, Oda Y, Honda H. Chronological changes in the expression pattern of hippocampal prion proteins during disease progression in sporadic Creutzfeldt-Jakob disease MM1 subtype. J Neuropathol Exp Neurol. 2022;81:900-909

 

  1. Yamakawa M, Nakane S, Ihara E, Tawara N, Ikeda H, Igarashi Y, Komohara Y, Takamatsu K, Ikeda T, Tomita Y, Murai S, Ando Y, Mukaino A, Ogawa Y, Ueda M. A novel murine model of autoimmune dysautonomia by α3 nicotinic acetylcholine receptor immunization. Front Neurosci. 2022;16:1006923

 

  1. Yi K, Nakajima M, Ikeda T, Yoshigai M, Ueda M. Modified Rankin scale assessment by telephone using a simple questionnaire. J Stroke Cerebrovasc Dis. 2022;31:106695

 

  1. Yoshimoto T, Yamagami H, Sakai N, Toyoda K, Hashimoto Y, Hirano T, Iwama T, Goto R, Kimura K, Kuroda S, Matsumaru Y, Miyamoto S, Ogasawara K, Okada Y, Shiokawa Y, Takagi Y, Tominaga T, Uno M, Yoshimura S, Ohara N, Imamura H, Sakai C. Impact of COVID-19 on the Volume of Acute Stroke Admissions: a Nationwide Survey in Japan. Neurol Med Chir (Tokyo). 2022;62:369-376

 

  1. Yoshimura H, Tanaka T, Fukuma K, Matsubara S, Motoyama R, Mizobuchi M, Matsuki T, Manabe Y, Suzuki J, Kobayashi K, Shimotake A, Nishimura K, Onozuka D, Kawamoto M, Koga M, Toyoda K, Murayama S, Matsumoto R, Takahashi R, Ikeda A, Ihara M. Impact of Seizure Recurrence on 1-year Functional Outcome and Mortality in Patients With Poststroke Epilepsy. 2022;99:e376-e384
Copyright© Department of Neurology, Graduate School of Medical Sciences, Kumamoto University.